Systemic vasculitis

Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study
Carlotta Nannini, Laura Niccoli, Stelvio Sestini, Iashar Laghai, Angela Coppola, Fabrizio Cantini

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1444-1446; DOI: 10.1136/annrheumdis-2019-215585
Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated
Nikolai Bulanov, Natalia V Chebotareva, Pavel I Novikov, Sergey V Moiseev

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e111; DOI: 10.1136/annrheumdis-2018-214095
Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study
Thomas Bettuzzi, Alban Deroux, Marie Jachiet, Meryem-Maud Farhat, julien wipff, Marc Fabre, Laurence Bouillet, Nora Kramkimel, Selim Aractingi, Nicolas Dupin, Benjamin Terrier

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1446-1448; DOI: 10.1136/annrheumdis-2019-215605
Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis
Sebastian Klapa, Antje Müller, Andreas Koch, Harald Heidecke, Wataru Kähler, Juliane Junker, Susanne Schinke, Gabriela Riemekasten, Peter Lamprecht

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1443-1444; DOI: 10.1136/annrheumdis-2019-215341
Response to: ‘Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated’ by Moiseev et al
Liang Wu, Min Chen

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e112; DOI: 10.1136/annrheumdis-2018-214145
Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis
Emily J Liebling, Rosemary Peterson, Teresa Victoria, Jon M Burnham

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e116; DOI: 10.1136/annrheumdis-2018-214191
Response to: ‘Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis’ by Liebling et al
Yoshikazu Nakaoka

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e117; DOI: 10.1136/annrheumdis-2018-214239
Response to: ‘Revised 2017 international consensus on ANCA testing in small vessel vasculitis: support from an external quality assessment’ by Broeders et al
Jan Damoiseaux

Annals of the Rheumatic Diseases Oct 2019, 78 (10) e114-e111; DOI: 10.1136/annrheumdis-2018-214243
Rituximab in ANCA-associated vasculitis: fewer infusions or ultra low-dose maintenance therapy?
Sergey V Moiseev, Nikolai M Bulanov, Anastasiia S Zykova, Pavel I Novikov

Annals of the Rheumatic Diseases Sep 2019, 78 (9) e99; DOI: 10.1136/annrheumdis-2018-213873
‘Not all drugs (and route) are same’
Abhishek Arvind Zanwar

Annals of the Rheumatic Diseases Aug 2019, 78 (8) e74; DOI: 10.1136/annrheumdis-2018-213730

Main menu

Systemic vasculitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic vasculitis

Pages